MOF, MHLW Push Conflicting Narratives on Drug Cost Control; Macroeconomic Indexing Is a Major Focus Too

Many in the pharma industry might have been taken aback by drug spending data recently presented by the Ministry of Finance (MOF). At a meeting on November 8 of its key advisory organ, the Fiscal System Council, the MOF submitted...read more